CCS
WX

Crosspoint Capital Strategies’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Crosspoint Capital Strategies’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-63
Closed -$2K – 1004
2015
Q4 		$2K Buy
+63
New +$2.83K ﹤0.01% 937

Other funds holding WX

HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Crosspoint Capital Strategies's WX Position: Q1 2016 in Review

Crosspoint Capital Strategies sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q1 2016, closing a stake of 63 shares — an estimated $2K sold.

Crosspoint Capital Strategies first reported a position in WX in Q4 2015 and held it in 1 quarter. The position peaked at $2K in Q4 2015. 1 fund tracked by Wall St. Rank holds WX as of Q1 2016.

  • Crosspoint Capital Strategies reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q1 2016 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 63 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q1 2016, an estimated $2K.
  • Crosspoint Capital Strategies first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q4 2015 and held it in 1 quarter.
  • Crosspoint Capital Strategies's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $2K in Q4 2015.
  • 1 fund tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q1 2016.

Based on Crosspoint Capital Strategies's 13F filing for Q1 2016, filed 16 May 2016.